Hepatic fibrosis, glomerulosclerosis, and a lipodystrophy-like syndrome in PEPCK-TGF-β1 transgenic mice

Journal of Clinical Investigation

Volumn 100, Issue 11, 1997, Pages 2697-2713

  Clouthier, David E ^a,b   Comerford, Sarah A ^a   Hammer, Robert E ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Kidney adipose tissue differentiation; Liver; TGF 1

Indexed keywords

PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BROWN ADIPOSE TISSUE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GLOMERULOSCLEROSIS; HEPATOMEGALY; LIPODYSTROPHY; LIVER FIBROSIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLENOMEGALY; SYNDROME; TRANSGENE; TRANSGENIC MOUSE; WHITE ADIPOSE TISSUE;

EID: 0031454239     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119815     Document Type: Article

References (65)

1. Kingsley, D.M. 1994. The TGF-β superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev. 8: 133-146.
2. ten Dijke, P., K. Miyazono, and C.H. Heldin. 1996. Signaling via heterooligomeric complexes of type I and type II serine/threonine kinase receptors. Curr. Opin. Cell Biol. 8:139-145.
3. Massague, J. 1996. TGF-β signaling: receptors, transducers and mad proteins. Cell. 85:947-950.
4. Wrana, J.L., and L. Attisano. 1996. MAD-related proteins in TGF-β signaling. Trends Genet. 12:493-496.
5. Roberts, A.B., and M.B. Sporn. 1987. Transforming growth factor-β: potential common mechanisms mediating its effects on embryogenesis, inflammation-repair, and carcinogenesis. Int. J. Radiat. Appl. Instrum. 14:435-439.
6. Border, W.A., and N.A. Noble. 1994. Transforming growth factor β in tissue fibrosis. N. Engl. J. Med. 331:1286-1292.
7. Border, W.A., and E. Ruoslahti. 1992. Transforming growth factor β in disease: the dark side of tissue repair. J. Clin. Invest. 90:1-7.
8. Fausto, N., J.E. Mead, P.A. Gruppuso, A. Castilla, and S.B. Jakowlew. 1991. Effects of TGF-β in the liver: cell proliferation and fibrogenesis. Ciba Found. Symp. 157:165-174.
9. Border, W.A., and N.A. Noble. 1994. Transforming growth factor-β in glomerular injury. Exp. Nephrol. 2:13-17.
10. Massague, J., and K. Polyak. 1995. Mammalian antiproliferative signals and their targets. Curr. Opin. Genet. Dev. 5:91-96.
11. Massague, J., S. Cheifetz, T. Endo, and B. Nadal-Girard. 1986. Type β transforming growth factor is an inhibitor of myogenic differentiation. Proc. Natl. Acad. Sci. USA. 83:8206-8210.
12. Ignotz R.A., and J. Massague. 1985. Type β transforming growth factor controls the adipogenic differentiation of 3T3 fibroblasts. Proc. Natl. Acad. Sci. USA. 82:8530-8534.
13. Sparks, R.L., and R.E. Scott. 1986. Transforming growth factor type β is a specific inhibitor of 3T3 T mesenchymal stem cell differentiation. Exp. Cell Res. 165:345-352.
14. Heino, J., and J. Massague. 1990. Cell adhesion to collagen and decreased myogenic gene expression implicated in the control of myogenesis by transforming growth factor β. J. Biol. Chem. 265:10181-10184.
15. Streuli, C.H., N. Bailey, and M.J. Bissell. 1991. Control of mammary epithelial differentiation: basement membrane induces tissue-specific gene expression in the absence of cell-cell interaction and morphological polarity. J. Cell Biol. 115:138-395.
16. Bortell, R., T.A. Owen, R. Ignotz, G.S. Stein, and J.L. Stein. 1994. TGF-β prevents the down regulation of type I procollagen, fibronectin and TGF-β1 gene expression associated with 3T3 L1 preadipocyte differentiation. J. Cell Biochem. 54:256-263.
17. Short, M.K., D.E. Clouthier, I.M. Schaefer, R.E. Hammer, M.A. Magnuson, and E.G. Beale. 1992. Tissue-specific, developmental, hormonal, and dietary regulation of rat phosphoenolpyruvate carboxykinase-human growth hormone fusion genes in transgenic mice. Mol. Cell. Biol. 12:1007-1020.
18. Hemsley, A., N. Arnheim, M.D. Toney, G. Cortopassi, and D.J. Galas. 1989. A simple method for site-directed mutagenesis using the polymerase chain reaction. Nucleic Acids Res. 17:6545-6551.
19. Ikeda, T., M.N. Lioubin, and H. Marquardt. 1987. Human transforming growth factor type β2: production by a prostatic adenocarcinoma cell line, purification, and initial characterization. Biochemistry. 26:2406-2410.
20. Ellis, L., E. Clauser, D.O. Morgan, M. Edery, R.A. Roth, and W.J. Rutter. 1986. Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2 deoxyglucose. Cell. 45:721-732.
21. Zhang, Y., R. Proenca, M. Maffei, M. Barone, L. Leopold, and J.M. Friedman. 1994. Positional cloning of the mouse obese gene and its human homologue. Nature. 372:425-432.
22. Chirgwin, J.M., A.E. Pryzbyla, R.J. MacDonald, and W.J. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 18:5294-5299.
23. Taurog, J.D., S.D. Maika, W.A. Simmons, M. Breban, and R.E. Hammer. 1993. Susceptibility to inflammatory disease in HLA-B27 transgenic rat lines correlates with the level of B27 expression. J. Immunol. 150:4168-4178.
24. Bradbury, P., and K.C. Gordon. 1990. Connective tissue and stains. In Theory and Practice of Histological Techniques. J.D. Bancroft and A. Stevens, editors. Churchill Livingstone, New York. 119-142.
25. Gavrieli, Y., Y. Sherman, and S.A. Ben-Sasson. 1992. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119:493-501.
26. Labarca, C., and K. Paigen. 1980. A simple, rapid, and sensitive DNA assay procedure. Anal. Biochem. 102:344-352.
27. Jirtle, R., and S.A. Meyer. 1991. Liver tumor promotion: effect of phenobarbital on EGF and protein kinase C signal transduction and transforming growth factor-β1 expression. Dig. Dis. Sci. 36:659-668.
28. Bartels, H., H. Herbort, and K. Jungermann. 1990. Predominant periportal expression of the phosphoenolpyruvate carboxykinase and tyrosine aminotransferase genes in rat liver. Histochemistry. 95:637-644.
29. Adachi, M., S. Suematsu, T. Londo, J. Ogasawara, T. Tanaka, N. Yoshida, and S. Nagata. 1995. Targeted mutation in the Fas gene causes hyperplasia in peripheral lymphoid organs and liver. Nat. Genet. 11:294-300.
30. Wu, H., M. Wade, L. Krall, J. Grisham, Y. Xiong, and T. Van Dyke. 1996 Targeted in vivo expression of the cyclin-dependent kinase inhibitor p21 halts hepatocyte cell-cycle progression, postnatal liver development, and regeneration. Genes Dev. 10:245-260.
31. Stolz, A., and N. Kaplowitz. 1990. Biochemical tests for liver disease. In Hepatology: A Textbook of Liver Disease. D. Zakim and T.D. Boyer, editors. W.B. Saunders Co., Philadelphia. 637-667.
32. Zimmer, D.B., and M.A. Magnuson. 1990. Immunohistochemical localization of phosphoenolpyruvate carboxykinase in adult and developing mouse tissues J. Histochem. Cytochem. 38:171-178.
33. Friedman, S.L., F.J. Roll, J. Boyles, and D.M. Bissell. 1985. Hepatic lipocytes: The principal collagen-producing cells of normal liver. Proc. Natl. Acad. Sci. USA. 82:8681-8685.
34. Casini, A., M. Pinzani, S. Milani, C. Grappone, G. Galli, A.M. Jezequel, D. Schuppan, C.M. Rotella, and C. Surrenti. 1993. Regulation of extracellular matrix synthesis by transforming growth factor β1 in human fat-storing cells. Gastroenterology. 105:245-253.
35. Gressner, A.M., and M.G. Bachem. 1995. Molecular mechanisms of liver fibrogenesis: a homage to the role of activated fat-storing cells. Digestion. 56:335-346.
36. Oberhammer, F.A., M. Pavelka, S. Sharma, R. Tiefenbacher, A.F. Purchio, W. Bursch, and R. Schulte-Hermann. 1992. Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor β. Proc. Natl. Acad. Sci. USA. 89:5408-5412.
37. Sanderson, N., V. Factor, P. Nagy, J. Kopp, P. Kondaiah, L. Wakefield, A.B. Roberts, M.B. Sporn, and S.S. Thorgeirsson. 1995. Hepatic expression of mature transforming growth β1 in transgenic mice results in multiple tissue lesions. Proc. Natl. Acad. Sci. USA. 92:2572-2576.
38. Bellamy ,C.O.C., R.D.G. Malcomson, D.J. Harrison, and A.H. Wyllie. 1995. Cell death in health and disease: the biology and regulation of apoptosis. Semin. Cancer Biol. 6:3-16.
39. Castilla, A., J. Prieto, and N. Fausto. 1991. Transforming growth factors β1 and α in chronic liver disease. Effects of interferon-α therapy. N. Engl. J. Med. 14:933-940.
40. Shull, M.M., I. Ormsby, A.B. Kier, S. Pawlowski, R.J. Diebold, M. Yin, R. Allen, C. Sidman, G. Proetzel, C. Galvin, et al. 1992. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature. 359:693-699.
41. Kulkarni, A.B., C.G. Huh, D. Becker, A. Geiser, M. Lyght, K.C. Flanders, A.B. Roberts, M.B. Sporn, J.M. Ward, and S. Karlsson. 1993. Transforming growth factor-β1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. USA. 90:770-774.
42. Russell, W.E., R.J. Coffey, Jr., A.J. Ouellette, and H.L. Moses. 1988. Type β transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat. Proc. Natl. Acad. Sci. USA. 85:5126-5130.
43. Schackert, H.K., D. Fand, and I.J. Fidler. 1990. Transient inhibition of liver regeneration in mice by transforming growth factor β1 encapsulated in liposomes. Cancer Commun. 2:165-171.
44. Kopp, J.B., V.M. Factor, M. Mozes, P. Nagy, N. Sanderson, E.P. Bottinger, P.E. Klotman, and S.S. Thorgiersson. 1996. Transgenic mice with increased plasma levels of TGF-β1 develop progressive kidney disease. Lab. Invest. 74-991-1003.
45. Tomooka, S., W.A. Border, B.C. Marshall, and N.A. Noble. 1992. Glomerular matrix accumulation is linked to inhibition of the plasmin protease system. Kidney Int. 42:1462-1469.
46. Feng, L., W.W. Tang, D.J. Loskutoff, and C.B. Wilson. 1993. Dysfunction of glomerular fibrinolysis in experimental antiglomerular basement membrane antibody glomerulonephritis. J. Am. Soc. Nephrol. 3:1753-1764.
47. Nath, K.A. 1992. Tubulointerstitial changes as a major determinant in the progression of renal damage. Am. J. Kid. Dis. 20:1-17.
48. Freidman A.L., and R.W. Chesney. 1993. Isolated renal tubular disorders. In Diseases of the Kidney. R.W. Schrier and C.W. Gottschalk, editors. Little, Brown and Company, Boston. 611-655.
49. Walton, G., R. Buttyan, E. Garcia-Montes, C.A. Olsson, T.W. Hensle, and I.S. Sawczuk. 1992. Renal growth factor expression during the early phase of experimental hydronephrosis. j. Urol. 148:510-514.
50. Border, W.A., S. Okuda, L.R. Languino, M.B. Sporn, and E. Ruoslahti. 1990. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1. Nature. 346:371-374.
51. Border, W.A., N.A. Noble, T. Yamamoto, J.R. Harper, Y.U. Yamaguchi, M.D. Pierschbacher, and E. Ruoslahti. 1992. Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease. Nature. 360:361-364.
52. Akagi, Y., Y. Isaka, M. Aria, T. Kaneko, M. Takenaka, T. Moriyama, Y. Kaneda ,A. Ando, Y. Orita, T. Kamada, et al. 1996. Inhibition of TGF-β1 expression by antisense oligonucleotides suppresses extracellular matrix accumulation in experimental glomerulonephritis. Kidney Int. 50:148-155.
53. Antonipillai, T., T. Hoang Le, L. Soceneantu, and R. Horton. 1993. Transforming growth factor-β is a renin secretagogue at picomolar concentrations. Am. J. Physiol. 265:F537-F541.
54. Kagami, S., W.A. Border, D.E. Miller, and N.A. Noble. 1994. Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-β expression in rat glomerular mesangial cells. J. Clin. Invest. 93:2431-2437.
55. Ketteler, M., N.A. Noble, and W.A. Border. 1995. Transforming growth factor-β and angiotensin II: the missing link from glomerular hyperfiltration to glomerulo-sclerosis? Ann. Rev. Physiol. 57:279-295.
56. Ailhaud, G., P. Grimaldi, and R. Negrel. 1992. Cellular and molecular aspects of adipose tissue development. Ann. Rev. Nutr. 12:207-233.
57. MacDougald, O.A., and M.D. Lane. 1995. Transcriptional regulation of gene expression during adipocyte differentiation. Ann. Rev. Biochem. 64:345-373.
58. Yeh, W.C., and S.L. McKnight. 1995. Regulation of adipose maturation and energy homeostasis. Curr. Opin. Cell Biol. 7:885-890.
59. Torti, P.M., S.V. Torti, J.W. Larrick, and G.M. Ringold. 1989. Modulation of adipocyte differentiation by tumor necrosis factor and transforming growth factor β. J. Cell Biol. 108: 1105-1113.
60. Sparks, R.L., B.J. Allen, and E.E. Strauss. 1992. TGF-β blocks early but not late differentiation-specific gene expression and morphologic differentiation of 3T3 T proadipocytes. J. Cell. Physiol. 150:568-577.
61. Vaidya, T.B., S.J. Rhodes, E.J. Taparowsky, and S.F. Konieczny. 1989. Fibroblast growth factor and transforming growth factor β repress transcription of the myogenic regulatory gene MyoD1. Mol. Cell. Biol. 9:3576-3579.
62. Brennan, T.J., D.G. Edmondson, L. Li, and E.N. Olson. 1991. Transforming growth factor β represses the actions of myogenin through a mechanism independent of DNA binding. Proc. Natl. Acad. Sci. USA. 88:3822-3826.
63. Spiegelman, B.M., and C.A. Ginty. 1983. Fibronectin modulation of cell shape and lipogenic gene expression in 3T3-adipocytes. Cell. 35:657-666.
64. Kozak, L.P., U.C. Kozak, and G.T. Clarke. 1991. Abnormal brown and white fat development in transgenic mice overexpressing glycerol 3-phosphate dehydrogenase. Genes Dev. 5:2256-2264.
65. Foster, D.W. 1994. The lipodystrophies and other rare disorders of adipose tissue. In Harrison's Principles of Internal Medicine. K.J. Isselbacher, E. Braunwald, J.D. Wilson, J.B. Martin, A.S. Fauci, and D.L. Kasper, editors. McGraw-Hill Inc., New York. 2132-2136.